Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Feds add $5.4B to address ‘pressures’ facing $10-a-day child-care program

June 19, 2026

Inuit call on Ottawa to be better partners or they will look abroad

June 19, 2026

Nothing cancels this year’s CMF phone due to RAM prices

June 19, 2026

Canada’s 1st judge dedicated to reconciliation appointed in Manitoba

June 19, 2026

James Burrows, prolific TV director and ‘Cheers’ co-creator, dead at 85

June 19, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Taurox (TAUX) Announced New Milestone: $1 Million in Presale, Signaling Strong Market Confidence
Press Release

Taurox (TAUX) Announced New Milestone: $1 Million in Presale, Signaling Strong Market Confidence

By News RoomApril 5, 20262 Mins Read
Taurox (TAUX) Announced New Milestone:  Million in Presale, Signaling Strong Market Confidence
Share
Facebook Twitter LinkedIn Pinterest Email

DUBAI, United Arab Emirates, April 05, 2026 (GLOBE NEWSWIRE) — Taurox, the innovative decentralized AI-powered trading protocol, has achieved a significant early milestone by raising over $1,000,000 in its ongoing presale. This impressive achievement, coming shortly after the project’s launch, highlights the growing enthusiasm and trust from investors in its vision of building a next-generation, AI-driven decentralized hedge fund.

Rapid Momentum in the Presale

The presale has gained remarkable traction in a very short period. With Phase 3, priced at $0.015 per token sold out, the project has successfully crossed the $1 million mark, demonstrating robust demand from both retail and sophisticated participants.

This fast-paced fundraising reflects the market’s positive reception of Taurox’s unique approach combining autonomous AI trading agents with a fully non-custodial and transparent protocol.

Taurox (TAUX) Announced New Milestone: $1 Million in Presale, Signaling Strong Market Confidence2

What This Represents

Reaching such a milestone in such a short period is more than just a funding target for the Taurox protocol. It serves as strong validation of the project’s core concept: creating a fair, efficient, and intelligent capital allocation system that removes traditional intermediaries and human biases.

The funds raised will support the continued development of critical infrastructure, including the dynamic capital allocation engine, advanced risk management systems, and the expansion of the AI agent ecosystem.

Strong Community Backing

The swift achievement of this milestone underscores the confidence investors have placed in Taurox’s roadmap and execution capabilities. Many participants have expressed excitement about the project’s focus on real utility, on-chain transparency, and measurable technical progress.

This level of early support has also accelerated the presale timeline, with Phase 3 now sold out much faster than initially anticipated.

Taurox (TAUX) Announced New Milestone: $1 Million in Presale, Signaling Strong Market Confidence3

Looking Ahead with Confidence

As Taurox celebrates this important milestone, the team remains committed to disciplined development and transparent communication. The project continues to tie future price increases to the achievement of concrete technical milestones, ensuring alignment between investor expectations and actual progress.

With the presale momentum building, the Taurox team is focused on delivering the next phase of development, including the full activation of autonomous agent integration and further enhancement of the protocol’s risk and allocation systems.

Learn More

Buy TAUX: https://taurox.io

Whitepaper: https://docs.taurox.io/

Official Telegram: https://t.me/tauroxlabs

Official X/Twitter: https://x.com/TauroxProtocol


            
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Dr. Austin Harris, MD Announces NAD+ IV Infusion Therapy Availability at NeuroRelief for Cellular Health and Cognitive Wellness Support in 2026

LuxuryShop Introduces Insights Into Evolving Craftsmanship Standards and Super Clone Watch Purchasing Trends

Gersan Elektrik Announces Application to Trade on the OTCQX Market in the United States

More Adults Are Turning to Better Sleep Hygiene in a Phone-Free Bedtime Environment

New England’s Top Marketing Executives Named at the 2026 BostonCMO ORBIE Awards

Playing For Change Unites Global Voices for Mother Earth with New Song Around The World, “Acontecer”

Comprehensive Healthcare opens Columbia Valley Center for Recovery, the Tri-Cities’ first inpatient behavioral health treatment and recovery facility

Cybersecurity Marketing Spend Benchmark Report 2026: Trust Emerges as the New Competitive Currency as Global Cybersecurity Market Eyes USD 375–400 Billion by 2030 | Vereigen Media

Gcore Helps Ucom Safeguard Public Live Broadcast Infrastructure During Armenia’s Parliamentary Elections

Editors Picks

Inuit call on Ottawa to be better partners or they will look abroad

June 19, 2026

Nothing cancels this year’s CMF phone due to RAM prices

June 19, 2026

Canada’s 1st judge dedicated to reconciliation appointed in Manitoba

June 19, 2026

James Burrows, prolific TV director and ‘Cheers’ co-creator, dead at 85

June 19, 2026

Latest News

Whale sanctuary in Nova Scotia holds groundbreaking ceremony despite setbacks

June 19, 2026

Silk beverage class-action settlement approved with payments of $400-$300K

June 19, 2026

Dr. Austin Harris, MD Announces NAD+ IV Infusion Therapy Availability at NeuroRelief for Cellular Health and Cognitive Wellness Support in 2026

June 19, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version